Novo Nordisk A/S buy mnake
Start price
05.10.15
/
50%
€49.80
Target price
02.12.15
€53.00
Performance (%)
7.32%
End price
02.12.15
€53.44
Summary
This prediction ended on 02.12.15 with a price of €53.44. With a performance of 7.32%, the BUY prediction by mnake for Novo Nordisk A/S closed with a slight gain. mnake has 50% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S | - | - | - | - |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% | 16.813% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% | 44.227% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% | 1.361% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% | 42.812% |
Comments by mnake for this prediction
In the thread Novo Nordisk A/S diskutieren
holt Anlauf
Novo Nordisk scheint jetzt Anlauf zu holen, fundamental stimmt alles, zum Jahresende sehe ich ein neues Hoch
Stopped prediction by mnake for Novo Nordisk A/S
Novo Nordisk A/S
Start price
Target price
Perf. (%)
€41.28
12.08.16
12.08.16
€49.00
11.11.16
11.11.16
-25.23%
11.11.16
11.11.16
